Integrating ethics with strategy: Analyzing disease-branding

Corporate Communications

Volumn 12, Issue 3, 2007, Pages 267-279

  Parsons, Patricia J ^a  

^a MOUNT SAINT VINCENT UNIVERSITY   (Canada)

Author keywords

Communication; Corporate communications; Corporate strategy; Ethics; Marketing communications; Public relations

Indexed keywords

EID: 34547653527     PISSN: 13563289     EISSN: None     Source Type: Journal    
DOI: 10.1108/13563280710776860     Document Type: Article

References (34)

1. American Marketing Association (2007), "Ethics norms and values for marketers", available at: www.marketingpower.com/content435.php (accessed March 2, 2007).
2. Arnst, C. (2006), "Hey, you don't look so good", Business Week, Vol. 3983, pp. 30-2.
3. Baker, S. (2004), "Five baselines for justification in persuasion", Journal of Mass Media Ethics, Vol. 14 No. 2, pp. 69-81.
4. BBC News (2006), "Drug firms inventing diseases", BBC News, available at: http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/4898488.stm (accessed June 02, 2006).
5. Bishop, J. (2000), "Is self-identity image advertising ethical?", Business Ethics Quarterly, Vol. 10 No. 2, pp. 371-8.
6. Bivins, T. (2004), Mixed Media: Moral Distinctions in Advertising. Public Relations and Journalism, Lawrence Erlbaum Associates, Publishers, Mahwah, NJ.
7. Burton, B. and Rowell, A. (2006), Disease Mongering, Center for Media and Democracy, Madison, WI, available at: www.prwatch.org/node/287/print (accessed June 02, 2006).
8. Center for Media Literacy (2006), "Language of media literacy: a glossary of terms", available at: www.medialit.org/readingroom/article565. html (accessed July 13, 2006).
9. Center on Global Brand Leadership (2006), "What is branding?", available at: www.globalbrands.org/center/branding.htm (accessed July 13, 2006).
10. Cui, G. and Choudhury, P. (2003), "Consumer interests and the ethical implications of marketing: a contingency framework", Journal of Consumer Affairs, Vol. 37 No. 2, pp. 364-87.
11. Dyer, O. (2006), "Disease awareness campaigns turn healthy people into patient", British Medical Journal, Vol. 332 No. 7546, p. 871.
12. Ewen, S. (1996), PR A Social History of Spin, Basic Books, New York, NY.
13. Fisher, J. (2001), "Lessons for business ethics from bioethics", Journal of Business Ethics, Vol. 34 No. 1, pp. 15-24.
14. Gershon, H. (2003), "The E in marketing: ethics in the age of misbehavior", Journal of Healthcare Management, Vol. 48 No. 5, pp. 292-4.
15. Health Canada (2005), "The distinction between advertising and other activities", available at: www.hc-sc.gc.ca/dhp-mps/altformats/hpfb-dgpsa/ pdf/advert-publicit/actvpromovsinfoe.pdf (accessed June 8, 2006).
16. Health Canada (2006), "Foods drugs and cosmetic devices", Food and drugs act. part 1, Section 3(1), available at: http://laws.justice.gc.ca/en/ f-27/61279.html (accessed July 14, 2006).
17. Jonsen, A. (1994), Clinical Ethics and the Four Principles, Wiley, New York, NY.
18. Koerner, B. (2002), "Disorders made to order", Mother Jones, Vol. 27, pp. 58-63, available at: www.motherjones.com/news/feature/2002/07/ disorders.html (accessed June 29, 2006).
19. Kotler, P. and Tybout, A. (Eds) (2005), Kellogg on Branding: The Marketing Faculty of the Kellogg School of Management, Wiley, New York, NY.
20. Laczniak, G. and Murphy, P. (1991), "Fostering ethical marketing decisions", Journal of Business Ethics, Vol. 10 No. 4, pp. 259-71.
21. Martin, D. (2006), "Rebuilding brand America: corporate America's role", Journal of Business Strategy, Vol. 27 No. 3, pp. 8-17.
22. Moynihan, R. (2003), "The making of a disease: female sexual dysfunction", British Medical Journal, Vol. 326 No. 7379, pp. 45-7.
23. Moynihan, R. and Cassels, A. (2005), Selling Sickness: How the World's Pharmaceutical Companies are Turning us all into Patients, Greystone Books, Vancouver.
24. Moynihan, R. and Henry, D. (2006), "The fight against disease mongering: generating knowledge for action", PLOS Medicine, Vol. 3 No. 4, pp. 425-8.
25. Parsons, P. (2004), Ethics in Public Relations: A Guide to Best Practice, Kogan Page, London.
26. Payer, L. (1992), Disease-Mongers: How Doctors, Drug Companies and Insurers are Making you Feel Sick, Wiley, New York, NY.
27. Preston, R. (1994), The Four Principles and their Use, Wiley, New York, NY.
28. Rossouw, G. (2003), "Business is not just war: transferring the principle of double effect from war to business", South African Journal of Philosophy, Vol. 22 No. 3, pp. 236-46.
29. Rotfeld, H. (2005), "The cynical use of marketing to the unwitting consumer", Journal of Consumer Marketing, Vol. 22 Nos 2/3, pp. 60-1.
30. Sarkar, A. and Singh, J. (2005), "New paradigm in evolving brand management strategy", Journal of Management Research, Vol. 5 No. 2, pp. 80-90.
31. Thomas, L. (1980), The Medusa and the Snail, Bantam Books, New York, NY.
32. US Food and Drug Administration (2004), "Prescription drug advertising", Code of Federal Regulations. Part 202, available at: http://a257.g.akamaitech.net/7/257/2422/12feb20041500/edocket.access.gpo.gov/ cfr2004/aprqtr/pdf/21cfr202.1.pdf (accessed July 14, 2006).
33. US Food and Drug Administration (2004), Federal Food, Drug and Cosmetic Act, Section 502(n) as amended through December 31, 2004, available at: www.fda.gov/opacom/laws/fdcact/fdcact5a.htm (accessed July 14, 2006).
34. Scott, M. and Mariani, G. (2006), "Media hype", New Scientist, Vol. 190 No. 2550, p. 24.